Top Stories
-
A panel discussion held in observance of National Physician Suicide Awareness Day on Sept. 17 highlighted the legacy of Dr. Lorna Breen and the ongoing fight to curb physician suicide.
Topic
-
Dr. Lourival Baptista-Neto speaks about CopeColumbia, where CUIMC employees can access psychological support and other support services.
Topic
-
Multiple neurons in the brain must fire in synchrony to create persistent memories tied to intense emotions, new research from Columbia neuroscientists has found.
Topic
-
Three CUIMC students have already put their naloxone training into action and saved the lives of strangers who had overdosed on opioids.
Topic
Latest News
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Topic
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
Topic
- May 6, 2016
After a manic episode, adults with bipolar disorder are just as likely to experience anxiety as depression, finds a new Columbia Psychiatry study.
Topic
- April 29, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
Topic
- April 19, 2016
Heavy cannabis use may alter the brain's dopamine system, revealing patterns of addiction commonly seen in other types of illicit drug use.
Topic
- April 11, 2016
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
Topic
- April 4, 2016
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
Topic
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
Topic
- March 16, 2016
Researchers from Columbia and the National Institute on Alcohol Abuse and Alcoholism have found that the number of Americans with marijuana use disorder has nearly doubled, but few get treatment.
Topic
- March 11, 2016
Researchers have found that treatment with very low doses of a dopamine-1 receptor (D1R) agonist was not effective in reducing the cognitive and negative symptoms of schizophrenia.
Topic
